Kevin Bitterman logo

Kevin Bitterman

Interim President at Editas Medicine · Investor at Atlas Venture

Investments
12
Lead Investments
5
Cambridge, Massachusetts, United States, US

Highlights

Focus Areas

Biotechnology
Therapeutics
Health Care
Medical
Pharmaceutical

Firms Invested Under

Recent Investments

Renasant Bio logo
GRO Biosciences logo
Chroma Medicine logo

Firm Investments